| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |